The invention relates to diaminopyrroloquinazoline compounds of formula (I) wherein R1, Ra, Rb, Rc, Rd, Re, Rf and A are as defined in the specification and claims, which are useful for inhibiting protein tyrosine phosphatases, particularly PTP1B, and are useful for lowering blood glucose concentrations in mammals.
本发明涉及式(I)的二
氨基
吡咯并
喹唑啉化合物,其中R1、Ra、Rb、Rc、Rd、Re、Rf和A如说明书和权利要求中所定义,这些化合物可用于抑制蛋白
酪氨酸磷酸酶,特别是
PTP1B,并可用于降低哺乳动物的血糖浓度。